Page 3 - Smart Score News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nvidia (NASDAQ:NVDA) is taking the market by storm, and it’s not just the stock that is benefiting. Three ETFs with big positions in Nvidia, the VanEck Semiconductor ETF (NASDAQ:SMH), the iShares U.S. Technology ETF (NYSEARCA:IYW), and the Invesco S&P Momentum ETF (NYSEARCA:SPMO) are reaping the rewards of Nvidia’s historic run and look poised to capture more upside if shares continues to rise. To find these ETFs featuring significant Nvidia exposure, I went to Nvidia’s page on TipRanks and used

Semiconductor stocks have unquestionably been the hottest part of the market, and the Invesco PHLX Semiconductor ETF (NASDAQ:SOXQ) is an excellent way for investors to play the semiconductor space. I’m bullish on this sometimes overlooked semiconductor ETF based on the strong historical performance of its underlying index, its highly-rated portfolio of top semiconductor stocks from across the semiconductor value chain, and its favorable expense ratio. What Is the SOXQ ETF’s Strategy? SOXQ is bas

The SPDR S&P Semiconductor ETF (NYSEARCA:XSD) is an interesting, diversified way to gain exposure to the semiconductor space. This ETF gives investors a different type of exposure to the semiconductor sector when compared to peers like the iShares Semiconductor ETF (NASDAQ:SOXX) and the VanEck Semiconductor ETF (NASDAQ:SMH). I’m bullish on this $1.5 billion ETF, as it has beaten the market over the long term and has a strong and diversified portfolio of top-rated semiconductor stocks. But there

The iShares Semiconductor ETF (NASDAQ:SOXX) is up a scorching 56.8% over the past year, but this powerhouse ETF could have plenty of additional...

When you’re looking for a stock sector with potential for big gains, you can’t help but look at the biotechs. These stocks are famous for their long product lead times and high overhead – bringing a new pharmaceutical to market can take years, and cost tens of millions of dollars – but for investors, their attraction lies in their potential. One piece of good news, be it a positive clinical trial result or meeting a regulatory milestone, can give a major boost to the share price. The trick is fi